Benzinga | Nov 12, 2020 04:27PM EST

Eton Pharmaceuticals Q3 EPS $(0.31) Misses $(0.25) Estimate, Sales $161.00K

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.25) by 24 percent. This is a 10.71 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $161.00 thousand in sales this quarter.